Fuxiang Zhou

机构：Wuhan University, Zhongnan Hospital of Wuhan University, Hubei Cancer Hospital · ORCID：0000-0001-9216-5395

发表论文 154 篇 · 总被引 3512 次 · h-index 24

代表论文

• Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial (2024 · Nature Medicine · 被引 38)
• A phase 1/2 study of LM-302, an anti-claudin 18.2 (CLDN18.2) antibody-drug conjugate in patients with advanced gastric/gastroesophageal junction cancer. (2024 · Journal of Clinical Oncology · 被引 17)
• Exploring the Molecular Mechanism of Comorbidity of Type 2 Diabetes Mellitus and Colorectal Cancer: Insights from Bulk Omics and Single-Cell Sequencing Validation (2024 · Biomolecules · 被引 9)
• Diagnostic Criteria for Cancer‐Associated Cachexia: Insights from a Multicentre Cohort Study (2025 · Journal of Cachexia Sarcopenia and Muscle · 被引 6)
• Bulk and single-cell RNA sequencing analyses coupled with multiple machine learning to develop a glycosyltransferase associated signature in colorectal cancer (2024 · Translational Oncology · 被引 5)
• TPP1 is associated with risk of advanced precursors and cervical cancer survival (2024 · PLoS ONE · 被引 4)